Bloom David E, Brenzel Logan, Cadarette Daniel, Sullivan Jessica
Harvard T.H. Chan School of Public Health, United States.
Bill & Melinda Gates Foundation, United States.
Vaccine. 2017 Jan 20;35 Suppl 1:A29-A35. doi: 10.1016/j.vaccine.2016.12.001. Epub 2016 Dec 22.
Economic evaluations of vaccination traditionally focus on a relatively narrow set of vaccine benefits, such as averted medical care costs among those who are immunized. In recent years, researchers have identified additional vaccination benefits that should be incorporated into economic evaluations in order to reflect vaccination's full value. Early efforts to estimate the magnitude of these broader benefits suggest that vaccination has been substantially undervalued, which has important implications for public and private vaccine policy and human health and welfare. More and better data will be required to advance this emerging line of research on the value of vaccination. The article discusses promising data sources and methods and research questions needing to be addressed.
传统上，疫苗接种的经济评估聚焦于相对有限的一系列疫苗益处，比如为接种疫苗者避免的医疗费用。近年来，研究人员已识别出其他应纳入经济评估的疫苗接种益处，以便反映疫苗接种的全部价值。早期估算这些更广泛益处规模的努力表明，疫苗接种一直被严重低估，这对公共和私人疫苗政策以及人类健康与福祉有着重要影响。推进这一关于疫苗接种价值的新兴研究领域需要更多更好的数据。本文讨论了有前景的数据来源、方法以及有待解决的研究问题。
